|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 14.12 USD | +2.54% |
|
-2.08% | -8.49% |
| 09-30 | Jade Biosciences, Inc. - Special Call | |
| 09-30 | Jade Biosciences, Inc. Announces Preclinical Data Characterizing Jade301 | CI |
Company Valuation: Jade Biosciences, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 709.8 | 898 | - | - |
| Change | - | 26.51% | - | - |
| Enterprise Value (EV) 1 | 373.7 | 552.3 | 544.3 | 562.1 |
| Change | - | 47.8% | -1.45% | 3.28% |
| P/E | -4.84x | -4.84x | -4.92x | -4.96x |
| PBR | - | 3.29x | 7.05x | 3.92x |
| PEG | -0.2x | 0.57x | 2.81x | 5.77x |
| Capitalization / Revenue | - | - | - | - |
| EV / Revenue | - | - | - | - |
| EV / EBITDA | - | -2.46x | -2.34x | -2.34x |
| EV / EBIT | -3.29x | -2.6x | -2.3x | -2.15x |
| EV / FCF | -3.94x | -3.22x | -2.33x | -2.23x |
| FCF Yield | -25.4% | -31.1% | -43% | -44.9% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -3.19 | -2.92 | -2.869 | -2.845 |
| Distribution rate | - | - | - | - |
| Net sales 1 | - | - | - | - |
| EBITDA 1 | - | -224.4 | -232.3 | -240.4 |
| EBIT 1 | -113.5 | -212.7 | -236.8 | -261.7 |
| Net income 1 | -127.4 | -204.2 | -231.1 | -258.9 |
| Net Debt 1 | -336.2 | -345.7 | -353.7 | -335.9 |
| Reference price 2 | 15.43 | 14.12 | 14.12 | 14.12 |
| Nbr of stocks (in thousands) | 46,004 | 63,597 | - | - |
| Announcement Date | 3/6/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.84x | - | -2.46x | - | 898M | |
| 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 18.39x | 31.37x | 10.98x | 0.31% | 39.14B | |
| Weighted average by Cap. | 22.21x | 32.04x | 13.52x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- JBIO Stock
- Valuation Jade Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
